Monopar Therapeutics Inc. buy BiotechBee
Start price
08.06.24
/
50%
€0.71
Target price
31.01.26
€1.00
Performance (%)
-37.59%
End price
14.12.24
-
Summary
This prediction is currently being closed. Massive losses of -37.59% have been the result for the BUY prediction by BiotechBee. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Monopar Therapeutics Inc. | - | - | - |
| iShares Core DAX® | -0,87 % | 5,32 % | 6,86 % |
| iShares Nasdaq 100 | -0,38 % | 1,98 % | 25,70 % |
| iShares Nikkei 225® | -1,68 % | 1,95 % | 41,44 % |
| iShares S&P 500 | -0,65 % | 2,07 % | 21,40 % |
According to BiotechBee what are the pros and cons of Monopar Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year